These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27639826)

  • 1. Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.
    Grün NG; Strohmeier K; Moreno-Viedma V; Le Bras M; Landlinger C; Zeyda K; Wanko B; Leitner L; Staffler G; Zeyda M; Stulnig TM
    Immunol Lett; 2016 Nov; 179():85-94. PubMed ID: 27639826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Cellular Adhesion by Immunological Targeting of Osteopontin Neoepitopes Generated through Matrix Metalloproteinase and Thrombin Cleavage.
    Jürets A; Le Bras M; Staffler G; Stein G; Leitner L; Neuhofer A; Tardelli M; Turkof E; Zeyda M; Stulnig TM
    PLoS One; 2016; 11(2):e0148333. PubMed ID: 26840958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance.
    Kiefer FW; Zeyda M; Gollinger K; Pfau B; Neuhofer A; Weichhart T; Säemann MD; Geyeregger R; Schlederer M; Kenner L; Stulnig TM
    Diabetes; 2010 Apr; 59(4):935-46. PubMed ID: 20107108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An accelerated mouse model for atherosclerosis and adipose tissue inflammation.
    Neuhofer A; Wernly B; Leitner L; Sarabi A; Sommer NG; Staffler G; Zeyda M; Stulnig TM
    Cardiovasc Diabetol; 2014 Jan; 13():23. PubMed ID: 24438079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-mediated targeting of cleavage-specific OPN-T cell interactions.
    Wanko B; Tardelli M; Jürets A; Neuhofer A; Prager G; Morser J; Leung LL; Staffler G; Zeyda M; Stulnig TM
    PLoS One; 2019; 14(4):e0214938. PubMed ID: 30951532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin is a key player for local adipose tissue macrophage proliferation in obesity.
    Tardelli M; Zeyda K; Moreno-Viedma V; Wanko B; Grün NG; Staffler G; Zeyda M; Stulnig TM
    Mol Metab; 2016 Nov; 5(11):1131-1137. PubMed ID: 27818939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations.
    Kiefer FW; Zeyda M; Todoric J; Huber J; Geyeregger R; Weichhart T; Aszmann O; Ludvik B; Silberhumer GR; Prager G; Stulnig TM
    Endocrinology; 2008 Mar; 149(3):1350-7. PubMed ID: 18048491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin is cleaved at multiple sites close to its integrin-binding motifs in milk and is a novel substrate for plasmin and cathepsin D.
    Christensen B; Schack L; Kläning E; Sørensen ES
    J Biol Chem; 2010 Mar; 285(11):7929-37. PubMed ID: 20071328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin.
    Lund SA; Wilson CL; Raines EW; Tang J; Giachelli CM; Scatena M
    J Cell Biochem; 2013 May; 114(5):1194-202. PubMed ID: 23192608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
    Wolak T
    Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin deletion prevents the development of obesity and hepatic steatosis via impaired adipose tissue matrix remodeling and reduced inflammation and fibrosis in adipose tissue and liver in mice.
    Lancha A; Rodríguez A; Catalán V; Becerril S; Sáinz N; Ramírez B; Burrell MA; Salvador J; Frühbeck G; Gómez-Ambrosi J
    PLoS One; 2014; 9(5):e98398. PubMed ID: 24871103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological blockade of adipocyte inflammation caused by increased matrix metalloproteinase-cleaved osteopontin in obesity.
    Leitner L; Schuch K; Jürets A; Itariu BK; Keck M; Grablowitz V; Aszmann OC; Prager G; Staffler G; Zeyda M; Stulnig TM
    Obesity (Silver Spring); 2015 Apr; 23(4):779-85. PubMed ID: 25776538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cryptic binding motif, LRSKSRSFQVSDEQY, in the C-terminal fragment of MMP-3/7-cleaved osteopontin as a novel ligand for α9β1 integrin is involved in the anti-type II collagen antibody-induced arthritis.
    Kon S; Nakayama Y; Matsumoto N; Ito K; Kanayama M; Kimura C; Kouro H; Ashitomi D; Matsuda T; Uede T
    PLoS One; 2014; 9(12):e116210. PubMed ID: 25545242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteopontin affects macrophage polarization promoting endocytic but not inflammatory properties.
    Schuch K; Wanko B; Ambroz K; Castelo-Rosa A; Moreno-Viedma V; Grün NG; Leitner L; Staffler G; Zeyda M; Stulnig TM
    Obesity (Silver Spring); 2016 Jul; 24(7):1489-98. PubMed ID: 27221527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer.
    Shojaei F; Scott N; Kang X; Lappin PB; Fitzgerald AA; Karlicek S; Simmons BH; Wu A; Lee JH; Bergqvist S; Kraynov E
    J Exp Clin Cancer Res; 2012 Mar; 31(1):26. PubMed ID: 22444159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin.
    Kon S; Ikesue M; Kimura C; Aoki M; Nakayama Y; Saito Y; Kurotaki D; Diao H; Matsui Y; Segawa T; Maeda M; Kojima T; Uede T
    J Exp Med; 2008 Jan; 205(1):25-33. PubMed ID: 18158320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of dual alpha 4beta1 integrin binding sites within a 38 amino acid domain in the N-terminal thrombin fragment of human osteopontin.
    Bayless KJ; Davis GE
    J Biol Chem; 2001 Apr; 276(16):13483-9. PubMed ID: 11278897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to Investigate Thrombin Cleavage of Osteopontin (OPN).
    Zhao L; Leung LL; Morser J
    Methods Mol Biol; 2024; 2747():95-117. PubMed ID: 38038935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A humanized osteopontin mouse model and its application in immunometabolic obesity studies.
    Grün NG; Zeyda K; Moreno-Viedma V; Strohmeier K; Staffler G; Zeyda M; Stulnig TM
    Transl Res; 2016 Dec; 178():63-73.e2. PubMed ID: 27490454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteopontin-integrin interaction as a novel molecular target for antibody-mediated immunotherapy in adult T-cell leukemia.
    Maeda N; Ohashi T; Chagan-Yasutan H; Hattori T; Takahashi Y; Harigae H; Hasegawa H; Yamada Y; Fujii M; Maenaka K; Uede T
    Retrovirology; 2015 Nov; 12():99. PubMed ID: 26597716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.